Macrophage index predicts short-term renal allograft function and graft survival

Transplant International

Volumn 17, Issue 4, 2004, Pages 195-201

  Srinivas, Titte R ^a   Kubilis, Paul S ^b   Croker, Byron P ^c  

^a UNIVERSITY OF FLORIDA   (United States)

^b FISH AND WILDLIFE RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Biopsy; Graft survival; Kidney; Macrophages; Transplantation

Indexed keywords

ARTICLE; CELL INFILTRATION; CHRONIC GRAFT REJECTION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; GLOMERULUS; GRAFT SURVIVAL; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; KIDNEY ALLOGRAFT; KIDNEY ALLOGRAFT REJECTION; KIDNEY BIOPSY; KIDNEY FUNCTION; KIDNEY GRAFT; LEUKOCYTE COUNT; MACROPHAGE INDEX; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; VALIDATION PROCESS;

BIOLOGICAL MARKERS; BIOPSY, NEEDLE; CREATINE; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; KIDNEY; KIDNEY TRANSPLANTATION; MACROPHAGES; MALE; PREDICTIVE VALUE OF TESTS; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 2942588727     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2004.tb00428.x     Document Type: Article

References (40)

1. Croker BP, Clapp WL, Abu Shamat AR, Kone BC, Peterson JC. Macrophages and chronic renal allograft nephropathy. Kidney Int Suppl 1996; 57:S42.
2. Pilmore HL, Painter DM, Bishop GA, McCaughan GW, Eris JM. Early upregulation of macrophages and myofibroblasts: a new marker for development of chronic renal allograft rejection. Transplantation 2000; 69:2658.
3. Pilmore HL, Eris JM, Painter DM, Bishop GA, McCaughan GW. Vascular endothelial growth factor expression in human chronic renal allograft rejection. Transplantation 1999; 67:929.
4. Grimm PC, McKenna R, Nickerson P, Russell ME, Gough J, Gospodarek E, et al. Clinical rejection is distinguished from subclinical rejection by increased infiltration by a population of activated macrophages. J Am Soc Nephrol 1999; 10:1582.
5. Azuma H, Nadeau KC, Ishibashi M, Tilney NL. Prevention of functional, structural, and molecular changes of chronic rejection of rat renal allografts by a specific macrophage inhibitor. Transplantation 1995; 60:1577.
6. Vos IH, Rabelink TJ, Dorland B, Loos R, Van Middelaar B, Grone HJ, et al. L-arginine supplementation improves function and reduces inflammation in renal allografts. J Am Soc Nephrol 2001; 12:361.
7. Vos IH, Govers R, Grone HJ, Kleij L, Schurink M, De Weger RA, et al. NFkappaB decoy oligodeoxynucleotides reduce monocyte infiltration in renal allografts. FASEB J 2001; 14:815.
8. Ramos EL, Barri YM, Croker BP, Clapp WL, Peterson JC, Wilcox CS. Thromboxane synthase expression in renal transplant patients with rejection. Transplantation 1995; 59:490.
9. Humar A, Hassoun A, Kandaswamy R, Payne WD, Sutherland DE, Matas AJ. Immunologic factors: the major risk for decreased long-term renal allograft survival. Transplantation 1999; 68:1842.
10. Isoniemi H, Taskinen E, Hayry P. Histological chronic allograft damage index accurately predicts chronic renal allograft rejection. Transplantation 1994; 58:1195.
11. Isoniemi H, Nurminen M, Tikkanen MJ, von Willebrand E, Krogerus L, Ahonen J, et al. Risk factors predicting chronic rejection of renal allografts. Transplantation 1994; 57:68.
12. Rush DN, Nickerson P, Jeffery JR, McKenna RM, Grimm PC, Gough J. Protocol biopsies in renal transplantation: research tool or clinically useful? Curr Opin Nephrol Hypertens 1998; 7:691.
13. Rush DN, Jeffery JR, Gough J. Sequential protocol biopsies in renal transplant patients. Clinico-pathological correlations using the Banff schema. Transplantation 1995; 59:511.
14. Rush DN, Jeffery JR, Gough J. Sequential protocol biopsies in renal transplant patients: repeated inflammation is associated with impaired graft function at 1 year. Transplant Proc 1995; 27:1017.
15. Berkes EA, Croker BP, Barri YM, Peterson JC, Wilcox CS, Ramos EL. Thromboxane synthase expression colocalizes with infiltrating macrophages in renal allograft biopsies. Kidney Int 1995; 48:1344.
16. Nusing R, Wernet MP, Ullrich V. Production and characterization of polyclonal and monoclonal antibodies against human thromboxane synthase. Blood 1990; 76:80.
17. Racusen LC, Solez K, Colvin RB, Bonsib SM, Castro MC, Cavallo T, et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55:713.
18. Isoniemi H, Ahonen J, Eklund B, Hayry P, Hockerstedt K, Krogerus L, et al. Relationship between renal histology and later graft outcome. Transpl Int 1994; 7 (Suppl 1): S318.
19. Kalbfleisch JD, Prentice RL. The statistical analysis of failure time data. John Wiley and Sons, New York, 1980.
20. Cox DR, Oakes D. Analysis of survival data. Chapman and Hall, London, 2002.
21. Nagelkerke NJ. A note on a general definition of the coefficient of determination. Biometrika 1991; 78:691.
22. Draper N, Smith H. Applied regression analysis, 2nd edn. John Wiley and Sons, New York, 1981.
23. Meier-Kriesche HU, Ojo AO, Hanson JA, Cibrik DM, Punch JD, Leichtman AB, et al. Increased impact of acute rejection on chronic allograft failure in recent era. Transplantation 2000; 70:1098.
24. Gaber LW. Role of renal allograft biopsy in multicenter clinical trials in transplantation. Am J Kidney Dis 1998; 31 (6 Suppl 1): S19.
25. Gaber LW, Moore LW, Gaber AO, First MR, Guttmann RD, Pouletty P, et al. Utility of standardized histological classification in the management of acute rejection. 1995 Efficacy Endpoints Conference. Transplantation 1998; 65:376.
26. Basadonna GP, Matas AJ, Gillingham KJ, Payne WD, Dunn DL, Sutherland DE, et al. Early versus late acute renal allograft rejection: impact on chronic rejection. Transplantation 1993; 55:993.
27. Opelz G. Critical evaluation of the association of acute with chronic graft rejection in kidney and heart transplant recipients. The Collaborative Transplant Study. Transplant Proc 1997; 29:73.
28. Nankivell BJ, Fenton-Lee CA, Kuypers DR, Cheung E, Allen RD, O'Connell PJ, et al. Effect of histological damage on long-term kidney transplant outcome. Transplantation 2001; 71:515.
29. Gaber LW, Schroeder TJ, Moore LW, Shakouh-Amiri MH, Gaber AO. The correlation of Banff scoring with reversibility of first and recurrent rejection episodes. Transplantation 1996; 61:1711.
30. Gaber LW, Moore LW, Alloway RR, Flax SD, Shakouh-Amiri MH, Schroder T, et al. Correlation between Banff classification, acute renal rejection scores and reversal of rejection. Kidney Int 1996; 49:481.
31. Messias NC, Eustace JA, Zachary AA, Tucker PC, Charney D, Racusen LC. Cohort study of the prognostic significance of acute transplant glomerulitis in acutely rejecting renal allografts. Transplantation 2001; 72:655.
32. Yilmaz S, Taskinen E, Hayry P, Isoniemi H. Protocol core biopsy as intermediate efficacy end-point in chronic kidney allograft rejection. Transplant Proc 1996; 28:491.
33. Gaber LW, Moore LW, Gaber AO, First MR, Guttmann RD, Pouletty P, et al. A multicenter report on the utilization of Banff grading in acute renal rejection. The 1995 Efficacy Endpoints Conference. Transplant Proc 1997; 29:184.
34. Lehtonen SR, Taskinen EI, Isoniemi HM. Histological alterations in implant and one-year protocol biopsy specimens of renal allografts. Transplantation 2001; 72:1138.
35. Hariharan S, Johnson CP, Bresnahan BA, Taranto SE, McIntosh MJ, Stablein D. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 1998; 342:605.
36. Hunsicker LG, Bennett LE. Design of trials of methods to reduce late renal allograft loss: the price of success. Kidney Int Suppl 1995; 52:S120.
37. Luster AD. The role of chemokines in linking innate and adaptive immunity. Curr Opin Immunol 2002; 14:129.
38. Croker BP, Tisher CC. Indications for and interpretation of the renal biopsy: evaluation by light, electron and immunofluorescence microscopy. In: Schrier RW, ed. Lippincott, Williams and Wilkins, Philadelphia, 2001: 457.
39. Fukao T, Frucht DM, Yap G, Gadina M, O'Shea JJ, Koyasu S. Inducible expression of Stat4 in dendritic cells and macrophages and its critical role in innate and adaptive immune responses. J Immunol 2001; 166:4446.
40. Croker BP, Ramos EL. Pathology of the renal allograft. In: Tisher CC, Brenner BM, eds. Renal pathology with clinical and functional correlations. Lippincott, Philadelphia, 1994: 1591.